NCT05384938 - FAsenra Safety Trial in India | Biotech Hunter

Enrollment

139

Participants

Timeline

Start Date

November 19, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions

In Adult Patients of Severe Asthma With Eosinophilic Phenotype in India

Interventions

BIOLOGICAL

Benralizumab

Prospective, Single-arm Study to Assess the Safety of Fasenra® (Benralizumab) in Adult Patients of Severe Asthma with Eosinophilic Phenotype in India

Trial Locations (13)

Research Site, Delhi

Research Site, New Delhi

Research Site, Noida

Research Site, Noida

Research Site, Lucknow

Research Site, Jaipur

Research Site, Jodhpur

Research Site, Mumbai

Research Site, Hyderabad

Research Site, Visakhapatnam

Research Site, Bengaluru

Research Site, Chennai

Research Site, Noida